Advertisement

Clinical and Experimental Medicine

, Volume 18, Issue 4, pp 585–593 | Cite as

Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review

  • Giovanna Di Meo
  • Lucia Ilaria Sgaramella
  • Valentina Ferraro
  • Francesco Paolo Prete
  • Angela Gurrado
  • Mario Testini
Review Article

Abstract

The aim of this report was to illustrate a case of parathyroid carcinoma (PC) in a patient with multiple endocrine neoplasia type 1 (MEN1) along with a comprehensive literature review. A 61-year-old man presented with 9-cm PC causing primary hyperparathyroidism (PHPT). His pre-operative corrected calcium and intact PTH serum levels were 2.92 mmol/L and 391.7 pg/mL, respectively. The neoplastic gland was removed in bloc with thyroid and central compartment lymph nodes. A literature review was run by searching PubMed MEDLINE from 1977 to 2018 for studies of all types, in the English language only, using the terms “Parathyroid, carcinoma, Multiple endocrine neoplasia, type 1, (MEN1).” Pathology confirmed PC. Post-operative calcium and PTH levels were normal. A diagnosis of MEN1 was established post-operatively. Seventeen cases of PC in patients with MEN1 have been reported in the literature. 59% of patients were men, and median age at diagnosis was 50 years, with median serum PTH of 379 pg/mL and median serum calcium level of 3.2 mmol/L. The occurrence of PC in the context of MEN1 is extremely rare. Diagnosis and treatment may represent a challenge, so opportune identification or suspicion of malignancy and adoption of correct surgical approach may offer affected patients the best outcome.

Keywords

Parathyroid carcinoma Multiple endocrine neoplasia type 1 MEN1 Primary hyperparathyroidism Cancer Surgery 

Abbreviations

PC

Parathyroid cancer

PHPT

Primary hyperparathyroidism

NET

Neuroendocrine tumours

MEN1

Multiple endocrine neoplasia type 1

Notes

Authors’ contributions

GDM contributed to conception and design of the study, case and literature review, draft writing, manuscript review, and intellectual input. LIS and VF contributed to case and literature review, draft writing, and manuscript review. FPP and AG contributed to draft writing, manuscript review, and intellectual input. MT helped in design and coordination of the study, draft writing, manuscript review, and intellectual input. All the authors read and approved the final manuscript.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985 and 1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.CrossRefGoogle Scholar
  2. 2.
    Singh Ospina N, Sebo TJ, Thompson GB, Clarke BL, Young WF Jr. Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1—case report and review of the literature. Clin Endocrinol (Oxf). 2014.  https://doi.org/10.1111/cen.12714.CrossRefGoogle Scholar
  3. 3.
    Wu CW, Huang CI, Tsai ST, Chiang H, Lui WY, P’eng FK. Parathyroid carcinoma in a patient with non-secretory pituitary tumor: a variant of multiple endocrine neoplasia type-I? Eur J Surg Oncol. 1992;18:517–20.PubMedGoogle Scholar
  4. 4.
    Sato M, Miyauchi A, Namihira H, et al. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine. 2000;12:223–6.CrossRefGoogle Scholar
  5. 5.
    Dionisi S, Minisola S, Pepe J, et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc. 2002;77:866–9.CrossRefGoogle Scholar
  6. 6.
    Agha A, Carpenter R, Bhattacharya S, Edmonson SJ, Carlsen E, Monson JP. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Investig. 2007;30:145–9.CrossRefGoogle Scholar
  7. 7.
    Shih RY, Fackler S, Maturo S, True MW, Brennan J, Wells D. Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract. 2009;15:567–72.CrossRefGoogle Scholar
  8. 8.
    Kalavalapalli S, Talapatra I, Patrick I. A complex case of multiple endocrine neoplasia type 1 with metastatic parathyroid carcinoma. Cent Eur J Med. 2010;5:53–8.Google Scholar
  9. 9.
    del Pozo C, García-Pascual L, Balsells M, et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones. 2011;10:326–31.CrossRefGoogle Scholar
  10. 10.
    Juodelė L, Serapinas D, Sabaliauskas G, et al. Carcinoma of two parathyroid glands caused by a novel MEN1 gene mutation—a rare feature of the MEN 1 syndrome. Medicina. 2011;47:635–9.CrossRefGoogle Scholar
  11. 11.
    Lee KM, Kim EJ, Choi WS, Park WS, Kim SW. Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient. J Clin Ultrasound. 2014;42:212–4.CrossRefGoogle Scholar
  12. 12.
    Christakis I, Busaidy NL, Cote GJ, et al. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016;31:10–6.CrossRefGoogle Scholar
  13. 13.
    Omi Y, Horiuchi K, Haniu K, et al. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case. Endocr J. 2017.  https://doi.org/10.1507/endocrj.EJ17-0409.CrossRefPubMedGoogle Scholar
  14. 14.
    Cinque L, Sparaneo A, Cetani F, et al. Novel association of MEN1 gene mutations with parathyroid carcinoma. Oncol Lett. 2017;14:23–30.CrossRefGoogle Scholar
  15. 15.
    Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485–93.CrossRefGoogle Scholar
  16. 16.
    Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRefGoogle Scholar
  17. 17.
    Goldfarb M, O’Neal P, Shih JL, Hartzband P, Connolly J, Hasselgren PO. Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr Pract. 2009;15(5):463–8.CrossRefGoogle Scholar
  18. 18.
    Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600.CrossRefGoogle Scholar
  19. 19.
    DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol. 2005;12:53–61.CrossRefGoogle Scholar
  20. 20.
    LiVolsi VA. Pathology of the parathyroid gland. In: Barnes L, editor. Surgical pathology of the head and neck. New York: Marcel Dekker; 1985. p. 1487.Google Scholar
  21. 21.
    Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94:566–70.CrossRefGoogle Scholar
  22. 22.
    Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990–3011.CrossRefGoogle Scholar
  23. 23.
    Guerrero MA. Cryopreservation of parathyroid glands. Int J Endocrinol. 2010;2010:829540.CrossRefGoogle Scholar
  24. 24.
    Cavallaro G, Iorio O, Centanni M, et al. Parathyroid reimplantation in forearm subcutaneous tissue during thyroidectomy: a simple and effective way to avoid hypoparathyroidism. World J Surg. 2015;39:1936–42.CrossRefGoogle Scholar
  25. 25.
    Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc. 2007;39:225–30.CrossRefGoogle Scholar
  26. 26.
    Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.CrossRefGoogle Scholar
  27. 27.
    Owen RP, Silver CE, Pellitteri PK, et al. Parathyroid carcinoma: a review. Head Neck. 2011;33:429–36.PubMedGoogle Scholar
  28. 28.
    Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010;34:2611–20.CrossRefGoogle Scholar
  29. 29.
    Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378–84.CrossRefGoogle Scholar
  30. 30.
    Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.CrossRefGoogle Scholar
  31. 31.
    Iacobone M, Citton M, Viel G, Schiavone D, Torresan F. Surgical approaches in hereditary endocrine tumors. Updates Surg. 2017;69:181–91.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Biomedical Sciences and Human Oncology – Unit of Endocrine, Digestive and Emergency SurgeryUniversity “A. Moro” of Bari. Polyclinic of BariBariItaly
  2. 2.Department of Emergency and Organ TransplantUniversity “A. Moro” of Bari. Polyclinic of BariBariItaly

Personalised recommendations